SCHEMBL7033451

SCHEMBL7033451

NCCCc1ccncn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 6/20 0.48
HSP90AA1 P07900 1/20 0.41
CYP2A6 P11509 1/20 0.41
LOXL2 Q9Y4K0 2/20 0.40
P2RX7 Q99572 1/20 0.36
AKT1 P31749 1/20 0.35
DYRK3 O43781 1/20 0.35
ROCK2 O75116 1/20 0.35
PRKD3 O94806 1/20 0.35
MAP4K4 O95819 1/20 0.35
PIM1 P11309 1/20 0.35
PRKACA P17612 1/20 0.35
RPS6KB1 P23443 1/20 0.35
CLK2 P49760 1/20 0.35
PRKX P51817 1/20 0.35
ROCK1 Q13464 1/20 0.35
DYRK1A Q13627 1/20 0.35
PRKG1 Q13976 1/20 0.35
PKN2 Q16513 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11813336 0.92 HRH1 (0.59) HRH1HSP90AA1HRH4HRH3
SCHEMBL29263652 0.92 HRH1 (0.59) HRH1HSP90AA1HRH4HRH3
SCHEMBL1661146 0.87
Hydrochloric Acid SCHEMBL3725860 0.85 HRH1 (0.52) HRH1HSP90AA1LOXL2P2RX7HRH4
SCHEMBL8835678 0.79 HSP90AA1 (0.37) HRH1HSP90AA1P2RX7HRH4HRH3
SCHEMBL5040818 0.79 HSP90AA1 (0.37) HRH1HSP90AA1P2RX7HRH4HRH3
SCHEMBL7897858 0.79 CYP2D6 (0.46) HSP90AA1HRH3KCNH3
SCHEMBL5040815 0.79 HSP90AA1 (0.37) HRH1HSP90AA1P2RX7HRH4HRH3
SCHEMBL244702 0.78
SCHEMBL655664 0.78 KCNH2 (0.47) HRH1HSP90AA1KCNH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743457-A1 INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 FOR THERAPEUTIC USE 4M THERAPEUTICS INC. (US) 2026-05-20 EP disclosed
WO-2025015045-A1 INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 FOR THERAPEUTIC USE 4M THERAPEUTICS INC. (US) 2025-01-16 WO disclosed
EP-1383747-A1 FUSED PYRIMIDINES AS ANTAGONISTS OF THE CORTICOTROPIN RELEASING FACTOR (CRF) GLAXO GROUP LIMITED (GB) 2004-01-28 EP disclosed
WO-2002088095-A1 FUSED PYRIMIDINES AS ANTAGONISTS OF THE CORTICOTROPIN RELEASING FACTOR (CRF) GLAXO GROUP LIMITED (GB) 2002-11-07 WO disclosed